Differentiating Anti-NMDA receptor encephalitis from other diseases: Difference between revisions
Created page with "__NOTOC__ {{Anti-NMDA receptor encephalitis}} {{CMG}} ==Overview== ==Differentiating Anti-NMDA Receptor Encephalitis from other Diseases== ==References== {{Reflist|2}} Ca..." |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Anti-NMDA receptor encephalitis}} | {{Anti-NMDA receptor encephalitis}} | ||
{{CMG}} | {{CMG}} ;AE {{DMakkar}} | ||
==Overview== | ==Overview== |
Revision as of 01:47, 1 January 2023
Anti-NMDA receptor encephalitis Microchapters |
Differentiating Anti-NMDA receptor encephalitis from Other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Differentiating Anti-NMDA receptor encephalitis from other diseases On the Web |
American Roentgen Ray Society Images of Differentiating Anti-NMDA receptor encephalitis from other diseases |
FDA on Differentiating Anti-NMDA receptor encephalitis from other diseases |
CDC on Differentiating Anti-NMDA receptor encephalitis from other diseases |
Differentiating Anti-NMDA receptor encephalitis from other diseases in the news |
Blogs on Differentiating Anti-NMDA receptor encephalitis from other diseases |
Directions to Hospitals Treating Anti-NMDA receptor encephalitis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;AE Dheeraj Makkar, M.D.[2]